Evidence map›Paper›PMID 22842185›Full record

ArticleIndian journal of cancer

Spectrum of malignancies among HIV-infected patients in South India.

K K Venkatesh, S Saghayam, B Devaleenal, S Poongulali, T P Flanigan, K H Mayer, N Kumarasamy

Abstract read
In one paragraph

Article in Indian journal of cancer. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Human immunodeficiency virus - associated lymphomas: a neglected domain.North American journal of medical sciences · 2013
    Article
  7. Recapitulation of acquired immuno deficiency syndrome associated Kaposi's sarcoma.Indian journal of sexually transmitted diseases and AIDS
    Review
  8. HIV-associated hematologic malignancies: Experience from a Tertiary Cancer Center in India.Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

K K VenkateshDivision of Infectious Diseases, Department of Medicine and Community Health, Alpert Medical School, Brown University/Miriam Hospital, RI, USA.
S Saghayam
B Devaleenal
S Poongulali
T P Flanigan
K H Mayer
N Kumarasamy
Brown University · USMiriam Hospital · US

Funding

Miriam/Brown/Tufts Fogarty AIDS International Training and Research ProgramD43TW000237 · FIC · MIRIAM HOSPITAL · PI CU-UVIN, SUSAN · 1993 to 2014
$10.6M
FIC NIH HHS D43 TW000237
6 · The paper itself

Abstract

introductionThe current study examines the spectrum of malignancies among HIV-infected South Indians enrolled in a clinical care program. MATERIALS AND

methodsWe conducted a nested matched case-control study among 42 HIV-infected cases who developed cancer and 82 HIV-infected controls between 1998 and 2008 at a tertiary care HIV care program in South India.

resultsThe most common types of cancer included non-Hodgkin's lymphoma (38.1%), Hodgkin's lymphoma (16.7%), squamous cell carcinoma (14.3%), and adenocarcinoma (14.3%). The median duration of time from HIV infection to cancer diagnosis was 549 days [interquartile range (IQR): 58-2013]. The nadir CD4 cell count was significantly lower in cases compared to controls (134 cells/μl vs. 169 cells/μl; P = 0.015). Cancer patients were more likely to have a more advanced HIV disease stage at the time of cancer diagnosis compared to control patients (Stage C: 90.5% vs. 49.4%; P<0.0001). Significantly more cancer patients were receiving antiretroviral treatment relative to control patients at the time of cancer diagnosis (92.9% vs. 66.3%; P=0.001).

conclusionsHIV-infected patients who developed cancer had more advanced immunodeficiency at the time of cancer diagnosis and a lower nadir CD4 cell count. It is possible that with the continued roll-out of highly active antiretroviral therapy in India, the incidence of HIV-associated malignancies will decrease.

Indexed as

AdenocarcinomaCarcinoma, Squamous CellHIV InfectionsHodgkin DiseaseLymphoma, Non-HodgkinAdultCase-Control StudiesCD4 Lymphocyte CountFemaleHumansIndiaMaleMiddle Aged

Identifiers

PMID22842185
PMCPMC5592840
OpenAlexW2048705834

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.